CBIS Seminar: A novel SARS-CoV-2 immunoassay based on force-dependent dissociation of molecular complexes by Yan Jie
Thursday, OCT 14 2021 | To contribute to the fight against COVID-19, we have been developing rapid SARS-CoV-2 antigen and antibiody immunoassay technologies, featured with high-sensitivity, high-specificity, and low-cost, which can be used for laboratory test, point-of-case, and home based tests.